Lesli McQuigg
Women's Health · Brunswick, GANPI 1851664445
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,540 of the $2,095 with a category attached, or 73.5%. 20 manufacturers reported payments, led by Intuitive Surgical at 25.0% of the total. Reporting peaked in 2024 at $674 and has fallen 79.1% since, to $141 in 2025. Among women's health clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 83 payments — averaging $25.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$523
- Astellas Pharma US Inc$343
- AbbVie$306
- Bayer$244
- Myriad Women's Health, Inc.$133
- Pfizer$112
- plus $435 from 14 others
What the payments were for
- Travel & lodging$39419%
- Food & beverage$1,54074%
- Education$1618%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 6 | $523 |
| Astellas Pharma US Inc | 13 | $343 |
| AbbVie | 18 | $306 |
| Bayer | 13 | $244 |
| Myriad Women's Health, Inc. | 1 | $133 |
| Pfizer | 7 | $112 |
| Therapeuticsmd, Inc. | 5 | $80 |
| Hologic Sales And Service, LLC | 4 | $74 |
| Organon | 4 | $68 |
| Mayne Pharma Commercial LLC | 2 | $48 |
| Sumitomo Pharma America, Inc. | 1 | $29 |
| Alydia Health | 1 | $19 |
| Scynexis, Inc. | 1 | $19 |
| Boston Scientific | 1 | $18 |
| Exact Sciences | 1 | $16 |
| KCI USA, Inc. | 1 | $16 |
| Convatec Inc. | 1 | $15 |
| Exeltis, USA Inc. | 1 | $12 |
| Amgen | 1 | $11 |
| Aspira Women's Health Inc | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$356
- myRisk$133
- DAVINCI XI$100
How this compares
$2,095 in reported general payments places this provider in the 90th percentile of 247 women's health providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 22 | $20,644 |
| Estradiol | 140 | $5,616 |
| Estradiol (Twice Weekly)Estradiol | 16 | $1,685 |
| ValacyclovirValacyclovir Hcl | 39 | $1,190 |
| ProgesteroneProgesterone, Micronized | 22 | $1,036 |
| Clobetasol Propionate | 15 | $617 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 25 | $197 |
| Fluconazole | 26 | $163 |
| Escitalopram Oxalate | 13 | $141 |
| Levothyroxine Sodium | 19 | $78 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $343 | $20,64422 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 247 women's health providers in Georgia.
Other women's health in Brunswick
- Sherri SellersSavannah$94K
- Jaclyn PiastaMarietta$8K
- Angela HurstMoultrie$5K
- Laurie RayAtlanta$5K
- Heather Thomas-OsuntokunAtlanta$3K
- Ania KirollosChamblee$3K
- Geneva RecordRinggold$3K
- Katie SellsSnellville$3K
- Susan AbbottAtlanta$3K
- Labrittany DavisAtlanta$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.